Zeneca ltd v pharmachemie bv order oct 27 2000 ii pharmachemie contends that the case is moot on appeal because it can no longer obtain the relief it sought in its complaint in light of the adverse final judgment on the validity of the patent. Zeneca ltd v pharmachemie bv no 96 12413 on april 3 1997 the fda tentatively approved pharmachemies anda to be effective at the earlier of the expiration of the statutory thirty month stay period or the period set forth by the court the date of a final court decision or the date of the expiration of the patent. Barr laboratories inc barr appeals the district courts grant of summary judgment interpreting the hatch waxman amendments of the federal food drug and cosmetic act 21 usc 301 et seq and regulations promulgated thereunder 21 cfr 31494 314107 to pharmachemie bv a potential competitor of barrs barr contends . Barr laboratories inc cases sudoc number court name uscourts 00 05206 pharmachemie b v v henney jane ju 211 united states. Opinion for mylan pharmaceuticals inc v henney 94 f supp 2d 36 brought to you by free law project a non profit dedicated to creating high quality open legal information
How it works:
1. Register a Free 1 month Trial Account.
2. Download as many books as you like ( Personal use )
3. No Commitment. Cancel anytime.
4. Join Over 100.000 Happy Readers.
5. That's it. What you waiting for? Sign Up and Get Your Books.